About 2% of global population suffers from OCD, of which only about 10% are receiving treatment.

Among CBT*, ERP** is first-line treatment for OCD, however, only 50% experience an improvement in OCD symptoms and the dropout rate is about 25%.


*Cognitive Behavioral Therapy

**Exposure and Response Prevention

OC Free not only improves the accessibility and effectiveness of existing OCD Treatments, but enhances the QOL* of patients through digitalized ERP treatment.


*Quality of Life

BIXINK strives to be a pioneer in developing Korea's first FDA-approved digital therapeutics, and is currently pursuing pilot study in the United States

CAUTION: Investigational Device. Limited by Federal law to investigational use.

OC Free™


Investigational SaMD for contamination OCD*

*Obsessive Compulsive Disorder

Development Status

Stage 1....  

Domestic Pilot study....

Stage 2

US Pilot study

.....Stage 3

.....US Pivotal study


BIXINK strives to be a pioneer in developing Korea's first FDA-approved digital therapeutics, and is currently pursuing pilot study in the United States

l OC Free™ l


Computerized Behavioral Therapy Device for OCD

CAUTION: Investigational Device.

Limited by Federal law to investigational use.

Copyright 2021 - BIXINK   │   Terms of Use

 Contact   │   Privacy

6F, 292 Gangnam-daero, Gangnam-gu, Seoul 06258, 

Republic of Korea

Copyright 2021 - BIXINK │ Terms of Use │ Contact  │  Privacy

6F, 292 Gangnam-daero, Gangnam-gu, Seoul 06258, Republic of Korea